Can gene tests predict chemo tolerance in elderly colon cancer patients?
NCT ID NCT02978612
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 28 times
Summary
This study involved 170 patients aged 75 and older with stage III colon cancer who had surgery. Researchers wanted to see how well they tolerated chemotherapy by measuring changes in daily living activities. They also looked at gene signatures to predict outcomes and improve patient selection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oslo University Hospital
Oslo, Norway
Conditions
Explore the condition pages connected to this study.